Palevsky P M, Washington M S, Stevenson J A, Rohay J M, Dyer N J, Lockett R, Perry S B
ESRD Network 4, the University of Pittsburgh School of Medicine, Pittsburgh, PA 15213-2582, USA.
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S11-20.
Dialysis dose has been established as a determinant of morbidity and mortality in chronic hemodialysis patients. To identify remediable barriers to the delivery of adequate hemodialysis, we examined factors that affected adherence to prescribed dialysis dose. End-Stage Renal Disease (ESRD) Network 4 facilities that fell into the lowest quintile in measures of dialysis adequacy were studied. At the time of this study, Network 4 was composed of 178 dialysis facilities in Delaware and Pennsylvania. Those 29 facilities had an average delivered urea reduction ratio (URR) of <0.67 and/or 71% of patients with a URR of 0.65. (The mean URR value of Network 4 was 0. 699 with a compliance ratio of 80%.) Dialysis treatment sheets were reviewed for all patients in the 29 facilities for all treatments during a calendar week. Predialysis and postdialysis blood urea nitrogen (BUN) values from 1 treatment during this week were used to calculate URR and Kt/V. A total of 1,339 patients with a mean age of 61.9 +/- 15.1 years and a mean duration of ESRD of 3.4 +/- 3.3 years were dialyzed in the 29 units. Mean prescribed duration of dialysis (T) was 219 +/- 26 min. with a mean blood flow rate (BFR) of 393 +/- 62 mL/min. Concordance between the prescribed and delivered T (-5 min), BFR (-50 mL/min), and hemodialyzer were assessed, by patient, for each treatment (Tx). Characteristics of a delivered Kt/V < 1.2 were duration <4 hours, BFR < 350 mL/min, patient weight > 100 kg, and delivered BFR 50 mL/min less than prescribed BFR. Multivariate analysis of the relationship between delivered dose of dialysis and patients and treatment characteristics identified black race, male gender, and younger age as demographic factors associated with low delivered dose. Potential remediable barriers identified by this analysis included reduced treatment time (>10%) and use of catheters for angioaccess. These data suggest components of the dialysis process that might be targeted in future quality improvement projects to improve the adequacy of dialysis delivery.
透析剂量已被确认为慢性血液透析患者发病率和死亡率的一个决定因素。为了确定在提供充分血液透析方面可补救的障碍,我们研究了影响对规定透析剂量依从性的因素。对终末期肾病(ESRD)网络4中透析充分性指标处于最低五分位数的机构进行了研究。在本研究开展时,网络4由特拉华州和宾夕法尼亚州的178个透析机构组成。这29个机构的平均尿素清除率(URR)<0.67,和/或71%的患者URR为0.65。(网络4的平均URR值为0.699,依从率为80%。)对这29个机构所有患者在一个日历周内的所有治疗的透析治疗记录单进行了审查。用本周一次治疗的透析前和透析后血尿素氮(BUN)值来计算URR和Kt/V。这29个单位共为1339例患者进行了透析,这些患者的平均年龄为61.9±15.1岁,ESRD平均病程为3.4±3.3年。规定的平均透析时长(T)为219±26分钟,平均血流量(BFR)为393±62毫升/分钟。针对每次治疗(Tx),按患者评估规定的和实际执行的T(相差-5分钟)、BFR(相差-50毫升/分钟)以及血液透析器之间的一致性。实际Kt/V<1.2的特征为透析时长<4小时、BFR<350毫升/分钟、患者体重>100千克以及实际BFR比规定BFR少50毫升/分钟。对实际透析剂量与患者及治疗特征之间关系的多变量分析确定,黑人种族、男性性别和较年轻年龄是与实际透析剂量低相关的人口统计学因素。该分析确定的潜在可补救障碍包括治疗时间减少(>10%)以及使用导管进行血管通路。这些数据表明了透析过程中可能在未来质量改进项目中作为目标以提高透析充分性的一些因素。